High vero cell density and rabies virus proliferation on fibracel disks versus Cytodex-1 in spinner flask

Pakistan Journal of Biological Sciences

Volumn 14, Issue 7, 2011, Pages 441-448

  Mehdi Hassanzadeh, S ^a   Zavareh, Ali ^a   Ali Shokrgozar, M ^a   Ramezani, Ali ^b   Fayaz, Ahmad ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytodex; Fibracel disk; Microcarrie; Rabies virus production; Vero cell

Indexed keywords

CYTODEX; DEXTRAN; FIBRACCEL; ORGANIC COMPOUND;

ANIMAL; ARTICLE; CELL PROLIFERATION; CERCOPITHECUS; COMPARATIVE STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; EVALUATION; GROWTH, DEVELOPMENT AND AGING; METHODOLOGY; RABIES VIRUS; VERO CELL; VIRUS CULTURE; VIRUS REPLICATION;

ANIMALS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; CULTURE MEDIA, SERUM-FREE; DEXTRANS; ORGANIC CHEMICALS; RABIES VIRUS; VERO CELLS; VIRUS CULTIVATION; VIRUS REPLICATION;

BOVINAE; RABIES VIRUS;

EID: 79960266708     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2011.441.448     Document Type: Article

References (43)

1. Daelli, M., 2007. Vero cell line which is adapted to grow in suspension, method of obtaining same and viral vaccines. WIPO, (WO/2007/039662). http://www.freepatentsonline.com/EP1942182.html.
2. De Oliveira Souza, M.C., M. da Silva Freire and L. dos Reis Castilho, 2005. Influence of culture conditions on vero cell propagation on non-porous microcarriers. Braz. Arch. Biol. Technol., 48: 71-77.
3. Doyle, A. and J.B. Griffiths, 1998. Cell and Tissue Culture: Laboratory Procedures in Biotechnology. John Wiley and Sons, New York, ISBN: 978-0-471-98255-5, pp: 352.
4. Fishbein, D.B., K.M. Yenne, D.W. Dreesen, C.F. Tephs, N. Mehta and D.J. Briggs, 1993. Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cell rabies vaccine: A nationwide prospective study. Vaccine, 14: 1390-1394.
5. Frazatti-Gallina, N.M., R.L. Paoli, R.M. Moura-Fuches, S.C. Jorge and C. A. Pereira, 2001. Higher production of rabies virus in serum-free medium cell cultures on microcarriers. J. Biotechnol., 92: 67-72.
6. Frazatti-Gallina, N.M., R.M. Mourao-Fuches, R.L. Paoli, M.L.N. Silvia and C. Miyaki et ah, 2004. Vero-cell rabies vaccine produced using serum-free medium. Vaccine, 23: 511-517.
7. Freshney, R.I., 2005. Culture of Animal Cells: A Manual of Basic Technique. 5fh Edn, John Wiley and Sons, Inc., New York.
8. Genari, C.S., L. Gomes and M. Wada, 1998. Alterations in the growth and adhesion pattern of Vero cells induced by nutritional stress conditions. Cell Biol. Int., 22: 285-294.
9. Glaser, V. and Bioreactor Fermentor Market Trends, 2009. Vaccine and biopharmaceutical product developments boost technological innovation. Genet. Eng. Biotechnol. News, 29: 1-4.
10. Gumusderelioglu, M., E. Aslankaraoglu and S. Gurhan, 2001. Rabies virus production in non-woven polyster fabric (NWPF) packed-bed reactors. Biotechnol. Applied Biochem., 33: 167-172.
11. Hassell, T., S. Gleave and M. Butler, 1991. The effect of lactate and ammonia. Applied Biochem. Biotechnol., 30: 29-41.
12. Hesse, F. and R. Wagner, 2000. Developments and improvements in the manufacturering of human therapeutics with mammalian cell cultures. Tibtech, 18: 173-180.
13. Hinterkorner, G., G. Brugger, D. Muller, F. Hesse, R. Kunert, H. Katinger and N. Borth, 2007. Improvement of the energy metabolism of recombinant CHO cells by cell sorting for reduced mitochondrial membrane potential. J. Biotechnol., 129: 651-657.
14. Horaud, F., 1992. Absence of viral sequences in the WHO-Vero cell bank: A collaborative study. Dev. Biol. Stand, 76: 43-46.
15. Jagannafhan, S., S. Chaansha, K. Rajesh, T. Santhiya, C. Charles and K.N. Venkataramana, 2009. Standardization and assessment of cell culture media quantities in roller poly ethylene terephfhalate bottles employed in the industrial rabies viral vaccine production. Pak. J. Biol. Sci., 12: 1246-1252.
16. Knobel, D.L., S. Cleaveland, P.G. Coleman, E.M. Fevre and M.I. Meltzer et al., 2005. Re-evaluating the burden of rabies in Africa and Asia. Bull. World Health Organ, 83: 360-368.
17. Kumar, A.A.P., Y.U.B. Rao, A.L.W. Joseph, K.R. Mam and K. Swaminathan, 2002. Process standardization for optimal virus recovery and removal of substrate DNA and bovine serum proteins in Vero cell derived rabies vaccine. J. Biosci. Bioeng., 94: 375-383.
18. Lubiniecki, A.S., 1999. Elimination of serum from cell culture medium. Dev. Biol. Stand, 99: 153-156.
19. Martinzn, L., 2000. Global infectious disease surveillance. Int. J. Infect Dis., 4: 222-228.
20. Mendonca, R.Z., L.M. Ioshimoto, R.M. Mendonca, M. De-Franco, E.J. Valentini et al., 1993. Preparation of human rabies vaccine in Vero cell culture using a microcarrier system. Braz. J. Med. Biol. Res., 26: 1305-1317.
21. Mendonca, R.Z. and C.A. Periera, 1995. High density Vero cell culture on microcarriers in a cell bioreactor. Bioprocess Biosyst. Eng., 12: 279-282.
22. Merten, O.W., J.V. Kierulff, N. Castignolles and P. Perrin, 1994. Evaluation of the new serum-free medium (MDSS2) for the production of different biological: Use of various cell lines. Cytotechnology, 14: 47-59.
23. Merten, O.W., H. Kallel, J.C. Manuguerra, M. Tardy-Panit and R. Crainic etal., 1999. The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses. Cytotechnology, 30: 191-201.
24. Merten, O.W., 2000. Safety for vaccine(e)s. Cytotechnology, 34: 181-183.
25. Meslm, F.X., D.B. Fishbem and H.C. Matter, 1994. Rationale and prospects for rabies elimination in developing countries. Curr. Trop. Microbiol. Immunol, 187: 1-26.
26. Montagnon, B.J., J.C. Vincent-Falquet and J.F. Saluzzo, 1999. Experience with vero cells at pasteur merieux connaught. Dev. Biol. Stand, 98: 137-140.
27. Namdev, P.K. and P. Lio, 2000. Assessing a disposable bioreactor for attachment-dependent cell cultures. Bio. Pharm., 13: 44-51.
28. Nandi, S. and M. Kumar, 2011. Global perspective of rabies and rabies related viruses: A comprehensive review. Asian J. Anim. Vet. Adv., 6: 101-116.
29. New Brunswick Scientific, 2006. Inoculation, growth and harvesting in a new easy-to-use disposable cell culture system. BioTechniques, 4: 1-5.
30. Paillet, C, G. Forno, R. Kratje and M. Etcheverrigaray, 2009. Suspension-Vero cell cultures as a platform for viral vaccine production. Vaccine, 27: 6464-6467.
31. Quesney, S., J. Marvel, A. Marc, C. Gerdil and B. Meignier, 2001. Characterization of Vero cell growth and death in bioreactor with serum-containing and serum-free media. Cytotechnology, 35: 115-125.
32. Rourou, S., A. Ark, T. Velden and H. Kallel, 2007. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Vaccine, 25: 3879-3889.
33. Rourou, S., A. venden Ark, S. Majoul, K. Trabelsi, T. ven den Velden and H. Kallel, 2009. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor. Applied Microbiol. Biotechnol., 85: 53-63.
34. Smith, J.S., P.A. Yager and G.M. Baer, 1973. A Rapid Tissue Culture Test for Determining Rabies Neutralizing Antibody. In: Laboratory Techniques in Rabies, Kaplan, M.M. and H. Koprowski (Eds.). WHO, Geneva, pp: 354-357.
35. Trabelsi, K., S. Rourou, H. Loukil, S. Majoul and H. Kallel, 2005. Comparison of virous culture modes for the production of rabies virus by Vero cells grown on microcarriers in a 2-1 bioreactor. Enzyme Microb. Biotechnol, 36: 514-519.
36. Trabelsi, K., S. Rourou, H. Loukil, S. Majoul and H. Kallel, 2006. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor. J. Biotechnol, 121: 261-271.
37. Vincent-Falquest, J.C, L. Peyron, M. Souvras, J.C. Moulin, J. Tektoff and J. Patet, 1989. Qualification of working cell banks for the vero cell line to produce licensed human vaccines. Dev. Biol. Stand, 70: 153-156.
38. Vyas, R. and J. Cino, 2005. High-yield single-use cell culture systems. Genet. Eng. News, 25: 1-4.
39. WHO, 2010. Weekly epidemiologica 1 record. 85th No. 32, 85, 309-320. http://www.who.int/wer/en/url
40. WHO., 2007. Meeting report of WHO study group on cell substrates for production of biologicals.
41. WHO Headquarters, Geneva. Wentz, D. and IK. Schiiger, 1992. Influence of lactate, ammonia and osmotic stress on adherent and suspension BHK cells. Enzyme Microb. Technol, 14: 68-75.
42. Yasumura, Y. and M. Kawakita, 1963. The research for the SV40 by means of tissue culture technique. Nippon Rmsho, 21: 1201-1219.
43. Yokomizo, A.Y., M.M. Antoniazzi, P.L. Galdino, N. Jr. Azambuja, S.A. Jorge and C.A. Pereira, 2004. Rabies virus production in high vero cell density cultures on macroporous microcarriers. Biotechnol. Bioeng., 85: 506-515